Hepatitis C virus infection and isoniazid hepatotoxicity.
Fernandez-Villar
Alberto
A
Leiro
Virginia
V
Botana
Maribel
M
Sopeña
Bernardo
B
D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects* / Q000627:therapeutic use; D008099:Liver / Q000187:drug effects*; D011379:Prognosis; D012307:Risk Factors; D019966:Substance-Related Disorders / Q000209:etiology*; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy*
D000995:Antitubercular Agents; D007538:Isoniazid